Birdwatch Archive

Birdwatch Note

2024-03-20 15:34:03 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Las avermectinas son derivados macrocíclicos de la lactona producidas por la actinobacteria Streptomyces avermitilis.​​ Son para infecciones de gusanos parásitos, no enfermedades de origen viral como el COVID. https://www.fda.gov/consumers/articulos-para-el-consumidor-en-espanol/por-que-no-debe-utilizar-la-ivermectina-para-tratar-o-prevenir-el-covid-19#:~:text=La%20ivermectina%20est%C3%A1%20aprobada%20para,eficaz%20contra%20el%20COVID%2D19.

Written by F337A1E9F13E6D0CA505B576B82F23C98A183D5CB742325973D05DADEE44E065
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1770438251800567834

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1770473888075440624
  • noteId - 1770473888075440624
  • participantId -
  • noteAuthorParticipantId - F337A1E9F13E6D0CA505B576B82F23C98A183D5CB742325973D05DADEE44E065 Participant Details
  • createdAtMillis - 1710948843388
  • tweetId - 1770438251800567834
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 1
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Las avermectinas son derivados macrocíclicos de la lactona producidas por la actinobacteria Streptomyces avermitilis.​​ Son para infecciones de gusanos parásitos, no enfermedades de origen viral como el COVID. https://www.fda.gov/consumers/articulos-para-el-consumidor-en-espanol/por-que-no-debe-utilizar-la-ivermectina-para-tratar-o-prevenir-el-covid-19#:~:text=La%20ivermectina%20est%C3%A1%20aprobada%20para,eficaz%20contra%20el%20COVID%2D19.

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-03-20 15:34:03 UTC
(1710948843388)
2024-03-21 01:30:52 UTC
(1710984652589)
CURRENTLY_RATED_HELPFUL 2024-03-21 01:30:52 UTC
(1710984652589)
CURRENTLY_RATED_HELPFUL 2024-03-21 01:30:52 UTC
(1710984652589)
CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2024-03-20 19:02:37 -0500 Rating Details
2024-03-20 16:50:52 -0500 Rating Details
2024-03-20 16:34:26 -0500 Rating Details
2024-03-20 16:20:53 -0500 Rating Details
2024-03-20 15:18:32 -0500 Rating Details
2024-03-20 14:14:48 -0500 Rating Details
2024-03-20 13:48:55 -0500 Rating Details
2024-03-20 13:33:38 -0500 Rating Details
2024-03-20 13:28:30 -0500 Rating Details
2024-03-20 13:25:13 -0500 Rating Details
2024-03-20 13:18:22 -0500 Rating Details
2024-03-20 13:00:46 -0500 Rating Details
2024-03-20 12:52:42 -0500 Rating Details
2024-03-20 12:51:28 -0500 Rating Details
2024-03-20 12:47:47 -0500 Rating Details
2024-03-20 12:40:24 -0500 Rating Details
2024-03-20 12:39:00 -0500 Rating Details
2024-03-20 12:20:04 -0500 Rating Details
2024-03-20 11:14:21 -0500 Rating Details
2024-03-20 11:03:34 -0500 Rating Details
2024-03-20 10:49:22 -0500 Rating Details
2024-03-21 15:23:21 -0500 Rating Details
2024-03-21 10:29:33 -0500 Rating Details
2024-03-21 07:31:14 -0500 Rating Details
2024-03-21 04:05:03 -0500 Rating Details
2024-03-21 01:50:24 -0500 Rating Details
2024-03-21 00:47:57 -0500 Rating Details
2024-03-20 22:34:47 -0500 Rating Details
2024-03-21 23:10:53 -0500 Rating Details
2024-03-21 12:12:05 -0500 Rating Details
2024-03-21 12:04:00 -0500 Rating Details
2024-03-21 10:27:32 -0500 Rating Details
2024-03-21 07:29:27 -0500 Rating Details
2024-03-21 06:20:05 -0500 Rating Details
2024-03-21 06:13:32 -0500 Rating Details
2024-03-21 05:33:11 -0500 Rating Details
2024-03-20 22:42:02 -0500 Rating Details
2024-03-20 20:51:20 -0500 Rating Details
2024-03-20 20:18:22 -0500 Rating Details
2024-03-20 17:00:20 -0500 Rating Details
2024-03-20 16:34:21 -0500 Rating Details
2024-03-20 16:34:20 -0500 Rating Details
2024-03-20 15:35:09 -0500 Rating Details
2024-03-20 15:30:12 -0500 Rating Details
2024-03-20 14:49:54 -0500 Rating Details
2024-03-20 14:38:58 -0500 Rating Details
2024-03-20 13:37:27 -0500 Rating Details
2024-03-20 12:54:32 -0500 Rating Details
2024-03-20 12:18:30 -0500 Rating Details
2024-03-20 11:56:21 -0500 Rating Details
2024-03-20 11:54:01 -0500 Rating Details
2024-03-20 11:49:26 -0500 Rating Details
2024-03-20 11:31:00 -0500 Rating Details
2024-03-20 11:26:12 -0500 Rating Details
2024-03-20 11:04:53 -0500 Rating Details
2024-03-20 11:04:06 -0500 Rating Details
2024-03-20 10:55:20 -0500 Rating Details
2024-03-20 10:38:46 -0500 Rating Details
2024-03-21 10:34:33 -0500 Rating Details
2024-03-21 05:19:17 -0500 Rating Details
2024-03-21 00:03:18 -0500 Rating Details
2024-03-20 22:40:09 -0500 Rating Details
2024-03-20 18:54:07 -0500 Rating Details
2024-03-20 17:25:14 -0500 Rating Details
2024-03-20 17:09:00 -0500 Rating Details
2024-03-20 17:00:51 -0500 Rating Details
2024-03-20 16:51:38 -0500 Rating Details
2024-03-20 16:37:15 -0500 Rating Details
2024-03-20 16:27:45 -0500 Rating Details
2024-03-20 16:17:21 -0500 Rating Details
2024-03-20 16:16:05 -0500 Rating Details
2024-03-20 15:32:21 -0500 Rating Details
2024-03-20 13:56:39 -0500 Rating Details
2024-03-20 13:48:18 -0500 Rating Details
2024-03-20 13:48:08 -0500 Rating Details
2024-03-20 13:47:53 -0500 Rating Details
2024-03-20 13:39:32 -0500 Rating Details
2024-03-20 13:01:02 -0500 Rating Details
2024-03-20 12:57:02 -0500 Rating Details
2024-03-20 12:43:52 -0500 Rating Details
2024-03-20 12:30:14 -0500 Rating Details
2024-03-20 12:10:41 -0500 Rating Details
2024-03-20 12:03:48 -0500 Rating Details
2024-03-20 11:35:11 -0500 Rating Details
2024-03-20 11:31:55 -0500 Rating Details
2024-03-20 11:12:36 -0500 Rating Details
2024-03-20 11:09:43 -0500 Rating Details
2024-03-20 10:57:16 -0500 Rating Details
2024-03-20 10:38:35 -0500 Rating Details